For the latest openings visit the Careers section of our website    CPL Biologicals launches Cadiflu-S, World’s First Virus Like Particle (VLP) Vaccine for Seasonal Influenza
Manufacturing
For the latest openings visit the Careers section of our website    CPL Biologicals launches Cadiflu-S, World’s First Virus Like Particle (VLP) Vaccine for Seasonal Influenza

News & Events

  • CPL Biologicals launches Cadiflu-S, World’s First Virus Like Particle (VLP) Vaccine for Seasonal Influenza Read More >>
Manufacturing

The manufacturing facilities of Cadila Pharmaceuticals conform to the most stringent international cGMP norms viz., WHO-GMP, WHO-Geneva (GDF site for Anti-TB), USFDA, TGA Australia (PIC/S), MHRA-UK, MCC-South Africa, ISO 9001 and ISO 14001

Dholka New Building
Dholka, Gujarat, India

Excellence in manufacturing facilities is central to Cadila Pharmaceuticals. The company’s formulations plat at Dholka near Ahmedabad, Gujarat is spread over hundred acres of land. This state-of-the-art facility is not only impressive in size, but is also USFDA approved.

Jammu_plant
Samba, Jammu, India

The second formulations manufacturing facility is located at Samba in Jammu and Kashmir. The facility meets most of the stringent quality standards across the globe to produce tablets, capsules, soft and hard gelatine capsules, liquids and orals.

Dholka
Ankleshwar, Gujarat, India

Two Active Pharmaceutical Ingredient (API) manufacturing units at Ankleshwar, Gujarat manufacture more than 50 APIs and intermediates including many USFDA-certified products.

Ankleshwar
Addis Ababa, Ethiopia

The company has also set up its first ever overseas formulation manufacturing facility at Addis Ababa in Ethiopia which is the only WHO-cGMP compliant manufacturing facility in the region.

Click here to view a video on Cadila Pharmaceuticals Ehtiopia manufacturing facility

Counterfeit Drugs : In case of any information on /or availability of counterfeit products...Read More © 2017 Cadila Pharmaceuticals all right reserved
Corporate identification No : U24231GJ1991PLC015132
Cadila Pharmaceuticals